<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02213159</url>
  </required_header>
  <id_info>
    <org_study_id>ANES.CZ.2</org_study_id>
    <nct_id>NCT02213159</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery</brief_title>
  <official_title>Intraoperative Dexmedetomidine Versus Morphine for Postoperative Analgesia After Laparoscopic Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American University of Beirut Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if Dexmedetomidine given at the end of surgery will
      reduce postoperative morphine consumption and improve postoperative quality of recovery as
      compared to morphine in patients undergoing laparoscopic bariatric surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      effect of Dexmedetomidine bolus on postoperative morphine requirements
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total dose of morphine consumed in Post Anesthesia Care Unit (PACU)</measure>
    <time_frame>At discharge from the PACU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first morphine requirement in PACU</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS) for Pain</measure>
    <time_frame>in the PACU and at 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NRS for nausea</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of pruritus</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of vomiting or retching</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of respiratory complications</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to discharge readiness in PACU</measure>
    <time_frame>in the PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total morphine consumption at 24 hours</measure>
    <time_frame>at 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery (QoR-40) score at 24 hours</measure>
    <time_frame>at 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall satisfaction at one month</measure>
    <time_frame>one month after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Obesity</condition>
  <condition>Sleep Apnea</condition>
  <condition>Diabetes</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prior to anticipated end of surgery bolus of 1 microgram/kg Dexmedetomidine intravenously over 10 minutes followed by 0.5 micrograms/kilogram/hour intravenous infusion until removal of laparoscopes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prior to anticipated completion of surgery morphine 0.08 mg/kilogram intravenous bolus over 10 minutes followed by a saline infusion until removal of the laparoscopes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <arm_group_label>Morphine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index &gt; 40 kg/m2 or BMI &gt; 35 kg/m2 with comorbid conditions such as
             hypertension, diabetes or sleep apnea

          -  American Society of Anesthesiologists class I or II

          -  Undergoing laparoscopic sleeve gastrectomy bariatric surgery

        Exclusion Criteria:

          -  Allergy to morphine or its derivatives

          -  Allergy to Î±-2 adrenergic agonists

          -  weight over 180 kg

          -  history of uncontrolled hypertension

          -  heart block greater than first degree

          -  prolonged QT interval

          -  clinically significant neurologic, cardiovascular, renal, hepatic, or gastrointestinal
             diseases

          -  received an opioid analgesic medication within a 24 h period prior to surgery

          -  history of alcohol, drug abuse or chronic opioid intake

          -  history of psychiatric disorder

          -  pregnant or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carine Zeeni, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AUBMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sahar Siddik, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AUBMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>American University of Beirut Medical Center</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2014</study_first_submitted>
  <study_first_submitted_qc>August 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2014</study_first_posted>
  <last_update_submitted>July 12, 2016</last_update_submitted>
  <last_update_submitted_qc>July 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>bariatric surgery</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>morphine consumption</keyword>
  <keyword>Quality of recovery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

